Sin3 inhibitors are a class of chemical compounds that specifically target and block the activity of the Sin3 protein, a key component of the Sin3 co-repressor complex involved in regulating gene expression. Sin3 functions as a scaffold protein, coordinating the assembly of large multi-protein complexes that include histone deacetylases (HDACs) and other chromatin-modifying enzymes. This complex plays a central role in transcriptional repression by deacetylating histones, leading to chromatin condensation and reduced accessibility of transcription factors to DNA. Sin3 is crucial for maintaining proper gene silencing across a wide range of cellular processes, including cell cycle regulation, DNA repair, and developmental pathways. Inhibitors of Sin3 are designed to interfere with these functions by targeting regions of the protein necessary for binding HDACs or other interacting partners, thereby disrupting the formation or activity of the co-repressor complex.
The development of Sin3 inhibitors involves detailed structural analysis of the protein to identify its functional domains, particularly those involved in mediating protein-protein interactions. Techniques such as X-ray crystallography, molecular docking, and computational modeling are employed to locate potential binding sites on Sin3 that could be targeted by inhibitors. These chemical compounds are then designed to fit into these critical sites, preventing Sin3 from interacting with other co-repressor components or altering its ability to recruit chromatin-remodeling enzymes. Once synthesized, these inhibitors are evaluated through a series of biochemical assays to test their binding affinity, specificity, and ability to modulate chromatin structure and gene expression. By inhibiting Sin3, researchers can gain insights into its role in gene repression and chromatin dynamics, as well as the broader mechanisms of epigenetic regulation that govern cellular behavior and developmental processes.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An HDAC inhibitor. By inhibiting HDACs, it can potentially disrupt the Sin3 repression complex. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
An HDAC inhibitor. Its inhibition of HDACs can affect the function and complex formation of Sin3. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
HDAC inhibitor that could potentially influence Sin3-mediated repression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Another HDAC inhibitor, known to influence several HDAC-associated complexes including those with Sin3. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Inhibits HDACs and can thus potentially influence Sin3's activity in transcriptional repression. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Specific HDAC inhibitor which could disrupt Sin3 complex actions. | ||||||
JNJ-26481585 | 875320-29-9 | sc-364515 sc-364515A | 5 mg 50 mg | $321.00 $1224.00 | ||
HDAC inhibitor which may impact Sin3 mediated pathways. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
A cyclic peptide HDAC inhibitor which can potentially interfere with Sin3 activities. | ||||||
Scriptaid | 287383-59-9 | sc-202807 sc-202807A | 1 mg 5 mg | $64.00 $183.00 | 11 | |
HDAC inhibitor which might affect Sin3 interactions and transcriptional repression. | ||||||
Tris Buffered Saline: 1 L of 1X | sc-362185 | 1 L | $21.00 | 3 | ||
Selectively inhibits HDAC6, affecting acetylation levels and possibly impacting Sin3 related pathways. | ||||||